February 22, 2019
Authored and Edited by Adriana L. Burgy; Thomas L. Irving; Stacy Lewis*
In Barry v. Medtronic, Inc., No. 17-2463 (Fed. Cir. Jan. 24, 2019), the CAFC majority affirmed the district court’s findings that Dr. Barry’s system and method claims were not invalid and that Medtronic infringed. The invention was not ready for patenting prior to the critical date, eliminating both the public use and on sale bars, and up to the critical date, there was only experimental use, not public use or sale. The CAFC held “experimental use negates invalidity under the public use bar.” The case involved two patents related to a spine correction device and related surgical methods. Further discussion of the decision can be found on Finnegan’s Prosecution First Blog.
United States Court of Appeals for the Federal Circuit (CAFC), on-sale bar, infringement, Food and Drug Administration (FDA)
*Stacy Lewis is a Law Clerk at Finnegan
Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
10th Annual Georgia Asian Pacific American Bar Association Gala
May 29, 2024
Atlanta
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.